Remodulin_treprostinil_Prior_Authorization_Request
Prior authorization request form used by CVS Caremark (for HMSA members) to collect clinical and administrative information for coverage determination of Remodulin (treprostinil) for pulmonary hypertension. The form requests diagnosis, prescribing specialist, WHO classification, right heart catheterization data, and site of administration/dispensing details.
No material clinical or coverage changes
Policy summary
CVS Caremark administers the prescription benefit for HMSA and requires prior authorization for certain medications, including Remodulin (treprostinil). Approvals may be subject to dosing limits consistent with FDA labeling, accepted compendia, and evidence-based practice guidelines.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.